Sana Biotechnology, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report2 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+4.99%
vs ±28.3% implied · ×0.18
shaded = implied · ▲▼ = realized
No thesis.
Sana Biotechnology, Inc.
2.56
−0.16 · −5.88%
post 2.56 0.00%
Fund move
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | FMRFMR | $130.6M | 20.18% | 0.00% | |
| 2 | Flagship PioneeringFlagship Pioneering | $87.3M | 13.48% | 0.00% | |
| 3 | RA Capital ManagementRA Capital Management | $65.4M | 10.11% | new | |
| 4 | BlackRockBlackRockindex-like | $58.2M | 8.99% | +17.10% | |
| 5 | State StreetState Streetindex-like | $39.1M | 6.04% | +6.31% | |
| 6 | Canada Pension Plan Investment BoardCanada Pension Plan Investment Board | $35.7M | 5.51% | −0.03% | |
| 7 | Vanguard Capital ManagementVanguardindex-like | $29.2M | 4.52% | +12.65% | |
| 8 | Bank of AmericaBank of America | $20.1M | 3.10% | +95.07% | |
| 9 | Geode Capital ManagementGeodeindex-like | $16.3M | 2.52% | +11.86% | |
| 10 | Marex GroupMarex | $13.9M | 2.15% | −0.25% | |
| 11 | Marshall WaceMarshall Wace | $10.2M | 1.58% | +341.18% | |
| 12 | AlphabetAlphabet | $9.8M | 1.52% | 0.00% | |
| 13 | Goldman Sachs GroupGoldman Sachs | $8.3M | 1.28% | −25.56% | |
| 14 | Integral Health Asset ManagementIntegral Health | $7.0M | 1.08% | −37.50% | |
| 15 | Toronto Dominion BankToronto Dominion Bank | $6.9M | 1.06% | new | |
| 16 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $6.6M | 1.01% | +10.20% | |
| 17 | Jacobs Levy Equity ManagementJacobs Levy Equity | $6.5M | 1.01% | new | |
| 18 | Northern TrustNorthern Trustindex-like | $5.6M | 0.86% | +8.47% | |
| 19 | Charles Schwab Investment ManagementCharles Schwabindex-like | $4.8M | 0.74% | +0.95% | |
| 20 | Woodline PartnersWoodline Partners | $4.6M | 0.71% | 0.00% | |
| 21 | Vanguard Fiduciary TrustVanguard Fiduciary Trustindex-like | $4.3M | 0.67% | +16.34% | |
| 22 | Renaissance TechnologiesRenaissance Technologies | $4.3M | 0.66% | −15.17% | |
| 23 | Morgan StanleyMorgan Stanley | $4.0M | 0.61% | −21.93% | |
| 24 | UBS GroupUBS | $3.7M | 0.57% | −21.68% | |
| 25 | AQR Capital ManagementAQR | $3.4M | 0.52% | −14.33% |
211 managers report $647.4M of Sana Biotechnology on form 13F for the quarter ended Jun 30 '26. 13 of them hold 80% of it; FMR is largest at 20.18%.
Linked news
NewsExpected move
Inputsspot 2.57exp Nov 20ATM strike 2.5ATM straddle 0.45IV 92%